Reaction
Product Design Issue reporting signals
As of the last recalculation, Product Design Issue appears in 671 FAERS reports alongside 6 co-occurring drug terms. The strongest observed disproportionality signal is TRAVOPROST (PRR 29.0).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Travoprost | 8 | 29.0 | 29.0 |
| Lifitegrast | 14 | 27.1 | 27.1 |
| Estradiol Gel 0.1% | 36 | 26.1 | 26.1 |
| Estradiol Transdermal | 36 | 26.0 | 26.1 |
| Estradiol | 58 | 22.7 | 22.7 |
| Guselkumab | 10 | 8.8 | 8.8 |